|Name||JWH 018 Benzimidazole Analog|
|Description||JWH-018 benzimidazole analog is a synthetic cannabinoid designer drug that is structurally similar to JWH-018, a cannabinoid receptor agonist with mild CB2 selectivity. Although the physiological and toxicological properties of this JWH-018
benzimidazole analog have not yet been tested, other benzimidazole analogs have been detected in herbal blends and have been shown to be selective CB2 receptor agonists.
JWH 018 benzimidazole analog was simultaneously identified by the Canada Border Services Agency and USACIL in herbal smoking mixtures and subsequently confirmed through independent reference standard synthesis at Cayman Chemical Company. This study highlights the importance of collaboration between forensic labs and reference material providers as well as the importance of rapid dissemination of information to quickly identify emerging drugs of abuse.
|Submitted By||Cayman Chemical|
Canada Border Services Agency, Ottawa, Canada
Defense Forensic Science Center, United States Army Criminal Investigation Laboratory (USACIL), Forest Park, Georgia
|Contact||Paul D. Kennedy, PhD. at Cayman Chemical|
Download the JWH 018 Benzimidazole Analog Monograph